We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$157M
Turnover
30.95%
1-Year Est. Return
60.08%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$112M
AUM Growth
-$13.3M
(-11%)
Cap. Flow
-$5.94M
Cap. Flow
% of AUM
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
38.7%
Holding
66
New
2
Increased
18
Reduced
11
Closed
9
Avg Time Held
2.3
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hasbro
HAS
|
+$1.31M |
| 2 |
Copa Holdings
CPA
|
+$1.19M |
| 3 |
Freeport-McMoran
FCX
|
+$895K |
| 4 |
Organon & Co
OGN
|
+$815K |
| 5 |
Pan American Silver
PAAS
|
+$671K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kyndryl
KD
|
+$3.22M |
| 2 |
Pfizer
PFE
|
+$1.74M |
| 3 |
Herc Holdings
HRI
|
+$1.28M |
| 4 |
Perrigo
PRGO
|
+$1.05M |
| 5 |
Warner Bros
WBD
|
+$976K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.52% |
| 2 | Materials | 10.9% |
| 3 | Industrials | 10.07% |
| 4 | Technology | 9.2% |
| 5 | Financials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Compass Therapeutics
CMPX
$161M
| $450K | 0.4% |
310,000
| – | – |
2023 Q4
4 quarters
|
|
52
DELISTED
Assertio
ASRT
| $348K | 0.31% |
26,667
+5,000
| +23% | +$74.5K |
2023 Q2
6 quarters
|
|
53
Battalion Oil
BATL
$59M
| $232K | 0.21% |
135,000
-5,000
| -4% | -$24.4K |
2020 Q4
16 quarters
|
|
54
Elicio Therapeutics
ELTX
$48.2M
| $204K | 0.18% |
40,000
-10,000
| -20% | -$49.2K |
2021 Q1
15 quarters
|
|
55
Edesa Biotech
EDSA
$25.7M
| $185K | 0.17% |
110,000
| – | – |
2022 Q3
9 quarters
|
|
56
Cognition Therapeutics
CGTX
$69.7M
| $140K | 0.13% |
200,000
-50,000
| -20% | -$24.7K |
2024 Q1
3 quarters
|
|
57
BioCardia
BCDA
$14.2M
| $54.5K | 0.05% |
+25,000
| New | +$58.6K |
2024 Q4
0 quarters
|
|
58
DELISTED
Cadence Bank
CADE
| – | – |
-10,000
| Closed | -$319K | – |
|
59
First Horizon
FHN
$10.8B
| – | – |
-25,000
| Closed | -$388K | – |
|
|
60
Herc Holdings
HRI
$4.15B
| – | – |
-8,000
| Closed | -$1.28M | – |
|
|
61
Kyndryl
KD
$2.87B
| – | – |
-140,000
| Closed | -$3.22M | – |
|
62
DELISTED
Kronos Bio
KRON
| – | – |
-200,000
| Closed | -$200K | – |
|
63
Newell Brands
NWL
$2.46B
| – | – |
-100,000
| Closed | -$768K | – |
|
|
64
Pfizer
PFE
$168B
| – | – |
-60,000
| Closed | -$1.74M | – |
|
|
65
Perrigo
PRGO
$2.29B
| – | – |
-40,000
| Closed | -$1.05M | – |
|
66
Palvella Therapeutics
PVLA
$1.83B
| – | – |
-22,500
| Closed | -$373K | – |
|
Similar funds
SFSG
PTFIS
AWMG
LDNAM
DFS
APW
GA
TC
CM Management's Q4 2024 Portfolio in Review
As of Q4 2024, CM Management held 66 positions worth $112M, down 11% from $125M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
CM Management withdrew a net $5.94M in Q4 2024, closing 9 positions and reducing 11 holdings. Its most notable exit was Kyndryl, an estimated $3.22M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 40% a quarter earlier, followed by Materials and Industrials.
Against the trend, CM Management opened a new position in Hasbro worth $1.12M.
- CM Management's largest Q4 2024 buy was Hasbro: 20,000 shares worth $1.12M.
- CM Management added most to Copa Holdings in Q4 2024, an estimated $1.19M increase.
- CM Management's biggest Q4 2024 reduction was Warner Bros, cutting an estimated $976K.
- CM Management fully exited Kyndryl in Q4 2024, selling an estimated $3.22M.
- CM Management's ten largest holdings make up 39% of its $112M portfolio in Q4 2024.
- CM Management opened 2 new positions and closed 9 in Q4 2024.
- CM Management's portfolio value fell 11% quarter-over-quarter to $112M.
Based on CM Management's 13F filing for Q4 2024, filed 7 Feb 2025.